Anna Lasorella

This inventor holds 7 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Columbia University, Other. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Lasorella. Retrieved from https://idiyas.com/inventor/anna-lasorella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 12)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

6 out of 2,554

Columbia University

patents

1 out of 834,513

Other

patents

Years Active: 2010-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12123005 - Fusion proteins and methods thereof (2024-10-22),

2. 12006503 - Fusion proteins and methods thereof (2024-06-11),

3. 11920138 - Fusion proteins and methods thereof (2024-03-05),

4. 11505788 - Fusion proteins and methods thereof (2022-11-22),

5. 11045525 - Compositions and methods for regulating activity of inhibitor of DNA binding-2 (ID2) protein and for treating ID protein-related diseases (2021-06-29),

6. 10208296 - Fusion proteins and methods thereof (2019-02-19),

7. 7816089 - Methods for diagnosing and treating pediatric neoplasms (2010-10-19),

Title: The Innovative Contributions of Anna Lasorella

Introduction

Anna Lasorella is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer research, particularly through her work on oncogenic fusion proteins. With a total of 7 patents to her name, her innovations are paving the way for new treatment methods for gene-fusion based cancers.

Latest Patents

Among her latest patents, one notable invention is titled "Fusion proteins and methods thereof." This invention discloses oncogenic fusion proteins and provides methods for treating gene-fusion based cancers. The implications of her work are profound, as they offer new avenues for therapeutic interventions in oncology.

Career Highlights

Anna has had a distinguished career, working at Columbia University, where she has been able to collaborate with leading experts in her field. Her research has not only advanced scientific understanding but has also contributed to practical applications in medicine.

Collaborations

Throughout her career, Anna has collaborated with esteemed colleagues such as Antonio Iavarone and Raul Rabadan. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Anna Lasorella's work exemplifies the intersection of innovation and practical application in the medical field. Her contributions to cancer research through her patents are invaluable and continue to inspire future advancements in treatment methodologies.

Profile summary based on public USPTO records.